Type 1 Papillary Renal Cell Carcinoma Active Not Recruiting Phase 2 Trials for Savolitinib (DB12048)

Also known as: Papillary Renal Cell Carcinoma Type 1

IndicationStatusPhase
DBCOND0029157 (Type 1 Papillary Renal Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02761057Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has ProgressedTreatment